ArticleSports health2026
Exploring Medical Professionals' Perspectives on Cannabinoid Use in Professional and Elite-Level Contact Sports: A Qualitative Inquiry.
Article in Sports health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe legalization and growing use of cannabis in elite sport raise concerns about the preparedness of sports medical staff, who often lack formal cannabinoid education and face regulatory, ethical, and communication challenges. HYPOTHESIS: Elite and professional contact sport medical staff have significant knowledge gaps, experience stigma, and face regulatory ambiguities that hinder open communication and athlete guidance on cannabis use. STUDY
designQualitative, descriptive study using thematic analysis of semi-structured interviews. LEVEL OF EVIDENCE: Level 4.
methodsSemi-structured interviews were conducted with 10 medical staff (physicians, athletic trainers, nutritionists, and mental health professionals) from elite sports leagues in North America and Australia including the NHL, NFL, and NCAA. Interviews explored knowledge, experiences, barriers, and communication regarding cannabis. Transcripts were inductively coded to identify themes.
resultsSix themes emerged: (1) pervasive "knowledge gap," with most staff lacking formal cannabis education and relying on informal sources; (2) compliance challenges and regulatory uncertainty due to inconsistent policies; (3) stigma and fear limiting open dialogue; (4) shifting attitudes as societal norms evolve; (5) observed increase in athlete cannabis use and inquiries for recreational and therapeutic purposes, highlighting a knowledge-practice gap; and (6) trust and communication as prerequisites for honest discussion and safe guidance. These factors restrict access to informed, evidence-based advice.
conclusionElite sport medical professionals face educational and regulatory barriers, compounded by stigma and inconsistent policies. Despite evolving attitudes, most lack knowledge and institutional support to advise athletes, underscoring the need for education, research, and clear guidelines. CLINICAL RELEVANCE: Targeted cannabinoid education, destigmatization, and clearer league policies are essential to optimize athlete care and harm reduction as cannabis use grows in elite sport.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.